Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bevacizumab for Prevention of Bleb Vascularization Post-Trabeculectomy
NCT00854529Phase 2Unknown
- Sponsor
- Rabin Medical Center
- Start
- Apr 2009
- Primary completion
- Apr 2011
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of bevacizumab in bleb fibrosis, sponsored by Rabin Medical Center. Status: unknown.
02
Drugs
bevacizumab
03
Conditions
bleb fibrosis
Beyond the preview
Go deeper on NCT00854529.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00854529.